Mangalam Drugs (India) Price Prediction
| MANGALAM | 106.68 0.21 0.20% |
Oversold Vs Overbought
30
Oversold | Overbought |
Quarterly Earnings Growth 0.148 | Quarterly Revenue Growth (0.12) |
Using Mangalam Drugs hype-based prediction, you can estimate the value of Mangalam Drugs And from the perspective of Mangalam Drugs response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Mangalam Drugs to buy its stock at a price that has no basis in reality. In that case, they are not buying Mangalam because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Mangalam Drugs after-hype prediction price | INR 106.3 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Mangalam |
Mangalam Drugs After-Hype Price Prediction Density Analysis
As far as predicting the price of Mangalam Drugs at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Mangalam Drugs or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Mangalam Drugs, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Mangalam Drugs Estimiated After-Hype Price Volatility
In the context of predicting Mangalam Drugs' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Mangalam Drugs' historical news coverage. Mangalam Drugs' after-hype downside and upside margins for the prediction period are 104.36 and 108.24, respectively. We have considered Mangalam Drugs' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Mangalam Drugs is very steady at this time. Analysis and calculation of next after-hype price of Mangalam Drugs And is based on 3 months time horizon.
Mangalam Drugs Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Mangalam Drugs is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mangalam Drugs backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Mangalam Drugs, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.33 | 1.94 | 0.38 | 206.47 | 1 Events / Month | 1 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
106.68 | 106.30 | 0.36 |
|
Mangalam Drugs Hype Timeline
Mangalam Drugs And is now traded for 106.68on National Stock Exchange of India of India. The entity has historical hype elasticity of -0.38, and average elasticity to hype of competition of -206.47. Mangalam is expected to decline in value after the next headline, with the price expected to drop to 106.3. The average volatility of media hype impact on the company price is about 170.18%. The price decline on the next news is expected to be -0.36%, whereas the daily expected return is now at -0.33%. The volatility of related hype on Mangalam Drugs is about 0.31%, with the expected price after the next announcement by competition of -99.79. About 55.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.14. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mangalam Drugs And recorded a loss per share of 4.03. The entity last dividend was issued on the 21st of December 2017. The firm had 10:1 split on the 29th of November 2016. Assuming the 90 days trading horizon the next expected press release will be very soon. Check out Mangalam Drugs Basic Forecasting Models to cross-verify your projections.Mangalam Drugs Related Hype Analysis
Having access to credible news sources related to Mangalam Drugs' direct competition is more important than ever and may enhance your ability to predict Mangalam Drugs' future price movements. Getting to know how Mangalam Drugs' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Mangalam Drugs may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MRF | MRF Limited | (2,583) | 3 per month | 0.00 | (0.28) | 1.57 | (1.78) | 4.82 | |
| HONAUT | Honeywell Automation India | (765.50) | 2 per month | 0.00 | (0.31) | 1.57 | (2.29) | 11.96 | |
| PAGEIND | Page Industries Limited | 843.88 | 1 per month | 1.24 | 0.01 | 3.44 | (2.46) | 9.34 | |
| 3MINDIA | 3M India Limited | 1.90 | 1 per month | 0.00 | (0.18) | 2.97 | (2.65) | 8.58 |
Mangalam Drugs Additional Predictive Modules
Most predictive techniques to examine Mangalam price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Mangalam using various technical indicators. When you analyze Mangalam charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Mangalam Drugs Predictive Indicators
The successful prediction of Mangalam Drugs stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Mangalam Drugs And, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Mangalam Drugs based on analysis of Mangalam Drugs hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Mangalam Drugs's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Mangalam Drugs's related companies.
Story Coverage note for Mangalam Drugs
The number of cover stories for Mangalam Drugs depends on current market conditions and Mangalam Drugs' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Mangalam Drugs is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Mangalam Drugs' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Mangalam Drugs Short Properties
Mangalam Drugs' future price predictability will typically decrease when Mangalam Drugs' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Mangalam Drugs And often depends not only on the future outlook of the potential Mangalam Drugs' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mangalam Drugs' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 15.8 M | |
| Cash And Short Term Investments | 11.9 M |
Complementary Tools for Mangalam Stock analysis
When running Mangalam Drugs' price analysis, check to measure Mangalam Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangalam Drugs is operating at the current time. Most of Mangalam Drugs' value examination focuses on studying past and present price action to predict the probability of Mangalam Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangalam Drugs' price. Additionally, you may evaluate how the addition of Mangalam Drugs to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |